Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease [PDF]
BACKGROUND: Lafora disease is an autosomal recessive form of progressive myoclonic epilepsy caused by defects in the EPM2A and EPM2B genes. Primary symptoms of the pathology include seizures, ataxia, myoclonus, and progressive development of severe ...
Agis Balboa, Roberto Carlos +3 more
core +1 more source
Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS)
Abstract Background Monoclonal gammopathy (MG) has been reported in association with numerous neurological disorders but the spectrum of MG‐associated myopathies remains poorly described. Objective To report a newly acquired myopathy associated with MG.
Katia Staedler +9 more
wiley +1 more source
A 48-year-old man of Ashkenazi Jewish descent developed neurogenic bladder and mild cognitive dysfunction. Neurologic examination and CSF analysis were unremarkable.
A. S. Lopez Chiriboga
semanticscholar +2 more sources
RBCK1‐related disease: A rare multisystem disorder with polyglucosan storage, auto‐inflammation, recurrent infections, skeletal, and cardiac myopathy—Four additional patients and a review of the current literature [PDF]
In this article, we report four new patients, from three kindreds, with pathogenic variants in RBCK1 and a multisystem disorder characterised by widespread polyglucosan storage.
Amer, H +18 more
core
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease [PDF]
Lafora disease (LD), the most devastating adolescence‐onset epilepsy, is caused by mutations in the EPM2A or EPM2B genes, which encode the proteins laforin and malin, respectively.
Augé Marí, Elisabet +6 more
core +1 more source
Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity [PDF]
Lafora disease (LD) is a fatal adolescence-onset neurodegenerative condition. The hallmark of LD is the accumulation of aberrant glycogen aggregates called Lafora bodies (LBs) in the brain and other tissues.
Aguilera, Mònica +4 more
core +1 more source
Temporopolar blurring signifies abnormalities of white matter in mesial temporal lobe epilepsy
Abstract Objective The single‐center retrospective cohort study investigated underlying pathogenic mechanisms and clinical significance of patients with temporal lobe epilepsy and hippocampal sclerosis (TLE‐HS), in the presence/absence of gray–white matter abnormalities (usually called “blurring”; GMB) in ipsilateral temporopolar region (TPR) on MRI ...
Yuming Li +15 more
wiley +1 more source
PRE-CLINICAL ADVANCEMENTS IN BIOMARKERS, TOOLS, AND THERAPEUTICS FOR A METABOLIC NEURODEGENERATIVE DISEASE [PDF]
Glycogen is the storage form of glucose and a highly important substrate for cellular metabolism. Characterization of the enzymes and mechanisms of glycogen metabolism began over 70 years ago and over the last 20 years, a previously unknown protein ...
Simmons, Zoë
core +1 more source
Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease [PDF]
The hallmark of Lafora disease, a fatal neurodegenerative disorder, is the accumulation of intracellular glycogen aggregates, called Lafora bodies. Until recently, it was widely believed that brain Lafora bodies were present exclusively in neurons and ...
Duran, Jordi +8 more
core +1 more source
What can pediatricians learn from adult inherited metabolic diseases?
Abstract The field of inherited metabolic diseases (IMD) has initially emerged and developed over decades in pediatric departments. Still, today, about 50% of patients with IMD are adults, and adult metabolic medicine (AMM) is getting more structured at national and international levels.
Fanny Mochel
wiley +1 more source

